PubMed

Treatment of mildly symptomatic human immunodeficiency virus (HIV) infection.

Hamilton JD, Simberkoff MS, Hartigan P.

Ann Intern Med. 1990 Oct 15;113(8):635-6. No abstract available. PMID: 2400172 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection.

Collier AC, Coombs RW, Fischl MA, Skolnik PR, Northfelt D, Boutin P, Hooper CJ, Kaplan LD, Volberding PA, Davis LG, Henrard DR, Weller S, Corey L.

Ann Intern Med. 1993 Oct 15;119(8):786-93.PMID: 8379600 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection.

Frissen PH, Weverling GJ, Endert E, Jansen J, Sauerwein HP, Lange JM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 15;12(5):482-8.PMID: 8757425 [PubMed - indexed for MEDLINE]Related articles

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, Jones M, Facey K, Whitacre C, McAuliffe VJ, Friedman HM, Merigan TC, Reichman RC, Hooper C, Corey L.

N Engl J Med. 1996 Apr 18;334(16):1011-7.PMID: 8598838 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection.

Floridia M, Vella S, Seeber AC, Tomino C, Fragola V, Weimer LE, Ricciardulli D, Milazzo F, Gritti FM, Mazzotta F, Ranieri S, Chiodo F, Moroni M, Cargnel A, Bassetti D, Giannini V, Cremoni L, Concia E, Sinicco A, Carosi G, Alberici F, Dianzani F.

J Infect Dis. 1997 Feb;175(2):255-64.PMID: 9203645 [PubMed - indexed for MEDLINE]Related articles

Virologic characterization of primary human immunodeficiency virus type 1 infection in a health care worker following needlestick injury.

Pratt RD, Shapiro JF, McKinney N, Kwok S, Spector SA.

J Infect Dis. 1995 Sep;172(3):851-4.PMID: 7658081 [PubMed - indexed for MEDLINE]Related articles

A controlled trial of zidovudine in primary human immunodeficiency virus infection.

Kinloch-De Loës S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A, Saurat JH, Clumeck N, Lazzarin A, Mathiesen L, et al.

N Engl J Med. 1995 Aug 17;333(7):408-13. Erratum in: N Engl J Med 1995 Nov 16;333(20):1367. PMID: 7616989 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al.

N Engl J Med. 1994 Nov 3;331(18):1173-80.PMID: 7935654 [PubMed - indexed for MEDLINE]Related articlesFree article

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.

Cooper DA, Gatell JM, Kroon S, Clumeck N, Millard J, Goebel FD, Bruun JN, Stingl G, Melville RL, González-Lahoz J, et al.

N Engl J Med. 1993 Jul 29;329(5):297-303.PMID: 8100611 [PubMed - indexed for MEDLINE]Related articlesFree article

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ Jr, Feinberg JE, Balfour HH Jr, Deyton LR, Chodakewitz JA, Fischl MA.

N Engl J Med. 1997 Sep 11;337(11):725-33.PMID: 9287227 [PubMed - indexed for MEDLINE]Related articlesFree article

Administration of zidovudine for treatment of infection due to human immunodeficiency virus.

Blott KW.

Rev Infect Dis. 1991 Jan-Feb;13(1):186-7. No abstract available. PMID: 2017626 [PubMed - indexed for MEDLINE]Related articles

Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study Group.

Kleim JP, Winters M, Dunkler A, Suarez JR, Riess G, Winkler I, Balzarini J, Oette D, Merigan TC.

J Infect Dis. 1999 Mar;179(3):709-13.PMID: 9952383 [PubMed - indexed for MEDLINE]Related articles

Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.

Bartlett JA, Benoit SL, Johnson VA, Quinn JB, Sepulveda GE, Ehmann WC, Tsoukas C, Fallon MA, Self PL, Rubin M.

Ann Intern Med. 1996 Aug 1;125(3):161-72.PMID: 8686973 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.

McKinney RE Jr, Johnson GM, Stanley K, Yong FH, Keller A, O'Donnell KJ, Brouwers P, Mitchell WG, Yogev R, Wara DW, Wiznia A, Mofenson L, McNamara J, Spector SA.

J Pediatr. 1998 Oct;133(4):500-8.PMID: 9787687 [PubMed - indexed for MEDLINE]Related articles

Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy.

Kojima E, Shirasaka T, Anderson BD, Chokekijchai S, Steinberg SM, Broder S, Yarchoan R, Mitsuya H.

J Infect Dis. 1995 May;171(5):1152-8.PMID: 7751690 [PubMed - indexed for MEDLINE]Related articles

Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1.

Sperber K, Chiang G, Chen H, Ross W, Chusid E, Gonchar M, Chow R, Liriano O.

Clin Ther. 1997 Sep-Oct;19(5):913-23.PMID: 9385480 [PubMed - indexed for MEDLINE]Related articles

Early intervention for human immunodeficiency virus disease.

Parra E.

West J Med. 1995 Jul;163(1):66-7. No abstract available. PMID: 7667986 [PubMed - indexed for MEDLINE]Related articlesFree article

Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection.

Frissen PH, van der Ende ME, ten Napel CH, Weigel HM, Schreij GS, Kauffmann RH, Koopmans PP, Hoepelman AI, de Boer JB, Weverling GJ, et al.

J Infect Dis. 1994 Jun;169(6):1351-5.PMID: 7910838 [PubMed - indexed for MEDLINE]Related articles

Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.

Jankelevich S, Mueller BU, Mackall CL, Smith S, Zwerski S, Wood LV, Zeichner SL, Serchuck L, Steinberg SM, Nelson RP, Sleasman JW, Nguyen BY, Pizzo PA, Yarchoan R.

J Infect Dis. 2001 Apr 1;183(7):1116-20. Epub 2001 Mar 1.PMID: 11237839 [PubMed - indexed for MEDLINE]Related articles

Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine. AIDS Clinical Trials Group Protocol 043 Study Group.

McKinney RE Jr, Wilfert C.

J Pediatr. 1994 Nov;125(5 Pt 1):728-33.PMID: 7965424 [PubMed - indexed for MEDLINE]Related articles